GlaxoSmithKline Reaches $2.2 Billion Settlement in Zantac Lawsuits

Author's Avatar
Oct 09, 2024
Article's Main Image

GlaxoSmithKline (GSK, Financial) has agreed to a substantial settlement in connection with lawsuits related to its Zantac product in U.S. state courts. The company announced that it reached settlements with 10 plaintiff firms, which represent a significant 93% of the cases filed against the pharmaceutical company regarding Zantac. The total settlement amount is up to $2.2 billion.

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.